Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Temporarily not available × Erlotinib Hydrochloride × Clear all

Status

Completed 391 Terminated 98 Unknown 68 Withdrawn 19 Active not recruiting 13 Recruiting 8 Suspended 2 Temporarily not available 1 Not yet recruiting 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 2 pembrolizumab 1 Taxes 1 Insulin Infusion Systems 1 FANG vaccine 1 Erlotinib Hydrochloride 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01297101 2011-02-16

Evaluating Efficacy and Safety of Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy

Shanghai Chest Hospital

Temporarily not available

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡